Orange Book product · Brand (NDA)
LO LOESTRIN FE
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
At a glance
Oct 21, 2010
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 21, 2010
15 yr 11 mo ago
Today
Patent 7704984 expires
Listed method-of-use patent (U-1090) expiration.
Feb 02, 2029
in 2 yr 8 mo
Pharmaceutical detail
Active ingredient
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Strength
0.01MG,0.01MG;1MG,N/A
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 022501
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2024FEMLYVBrand (NDA)
NDA 218718 · MILLICENT PR
- 2013LO MINASTRIN FEBrand (NDA)
NDA 204654 · APIL
- 2013MINASTRIN 24 FEBrand (NDA)
NDA 203667 · APIL
- 2013TAYTULLABrand (NDA)
NDA 204426 · APIL
- 2006LOESTRIN 24 FEBrand (NDA)
NDA 021871 · TEVA BRANDED PHARM
- 2005FEMHRTBrand (NDA)
NDA 021065 · APIL
- 1996ESTROSTEP 21Brand (NDA)
NDA 020130 · APIL
- —LOESTRIN 21 1.5/30Brand (NDA)
NDA 017875 · TEVA BRANDED PHARM
- —LOESTRIN 21 1/20Brand (NDA)
NDA 017876 · TEVA BRANDED PHARM
- —LOESTRIN FE 1.5/30Brand (NDA)
NDA 017355 · TEVA BRANDED PHARM
- 2023OSHIHGeneric (ANDA)
ANDA 216558 · AUROBINDO PHARMA
- 2022NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATEGeneric (ANDA)
ANDA 213418 · GLENMARK PHARMS LTD
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7704984 | Feb 02, 2029 | in 2 yr 8 mo | U-1090 |
